All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
04/02/24	4	Statement of changes in beneficial ownership of securities	1
04/02/24	4	Statement of changes in beneficial ownership of securities	1
04/02/24	144	Filing for proposed sale of securities under Rule 144	2
03/27/24	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5.1 EX-23.2 EX-FILING FEES	8
03/27/24	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-4.1 EX-10.26 EX-21.1 EX-23.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2 EX-97.1	162
02/14/24	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	5
02/13/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	11
02/13/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	10
02/13/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents EX-99.A	9
02/09/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	14